Xellar Biosystems
HTS Organ-on-Chip Drug Discovery Platform
Xellar Biosystems was founded in 2022, is headquartered in Boston, United States, lists 11–50 employees, and has $50.0M in recorded funding across 3 rounds.
- Headquarters
- Boston
- Employees
- 11–50
- Founded
- 2022
- Business Model
- B2B
- Website
- xellarbio.com
- Total Funding
- $50.0M
- Last Round
- $50.0M Series AJun 2026
- Rounds
- 3
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 3 funding rounds and 5 investors for this company. The full record is or through the API.
About
Xellar Biosystems has developed the world's first pharmaceutical-scale organ-on-chip platform, combining high-throughput screening with advanced image-based AI to enable more predictive drug discovery while reducing reliance on animal testing. The company's four-core E.P.I.C. platform integrates microfluidic chip engineering, pharma-scale drug testing, high-content 3D imaging, and an AI computation pipeline in a closed-loop feedback cycle that delivers 90% predictive accuracy versus 50-65% with live animals. Xellar partners with pharmaceutical leaders including Sanofi to develop organ-on-chip models for vascular toxicity and other preclinical applications.
Summary
Xellar Biosystems is a Biotech company based in Boston, United States, founded in 2022. It lists 11–50 employees. It has raised $50.0M in total across 3 rounds, most recently a $50.0M Series A round in Jun 2026. Investors include XtalPi, Legend Star and K2VC.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jun 2026
Sign up to see all 3 events
Funding: Angel through Series A. Amounts, valuations, and investors where available.
Investors
Similar Companies
Altos Labs combines academic science and industry development to create medicines that restore ce...
BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/xellar-biosystems"><img src="https://indexed.vc/api/badge/company/xellar-biosystems" alt="Xellar Biosystems on Indexed.vc" width="260" height="76" /></a>